|
1
|
Maliszewski CR, Delespesse GJ, Schoenborn
MA, et al: The CD39 lymphoid cell activation antigen. Molecular
cloning and structural characterization. J Immunol. 153:3574–3583.
1994.PubMed/NCBI
|
|
2
|
Koziak E, Sevigny J, Robson SC, Siegel JB
and Kaczmarek K: Analysis of CD39/ATP diphosphohydrolase (ATPDase)
expression in endothelial cells, platelets and leukocytes. Thromb
Haemost. 82:1538–1544. 1999.PubMed/NCBI
|
|
3
|
Day YJ, Huang L, Ye H, Li L, Linden J and
Okusa MD: Renal ischemia-reperfusion injury and adenosine 2A
receptor-mediated tissue protection: the role of CD4+T
cells and IFN-gamma. J Immunol. 176:3108–3114. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ohta A and Sitkovsky M: Role of
G-protein-coupled adenosine receptors in downregulation of
inflammation and protection from tissue damage. Nature.
414:916–920. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Erdmann AA, Gao ZG, Jung U, Foley J,
Borenstein T, Jacobson KA and Fowler DH: Activation of Th1 and Tc1
cell adenosine A2A receptors directly inhibits IL-2 secretion in
vitro and IL-2-driven expansion in vivo. Blood. 105:4707–4714.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sipka S, Kovacs I, Szanto S, Szegedi G,
Brugos L, Bruckner G and Jozsef Szentmiklosi A: Adenosine inhibits
the release of interleukin-1beta in activated human peripheral
mononuclear cells. Cytokine. 31:258–263. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lappas CM, Rieger JM and Linden J: A2A
adenosine receptor induction inhibits IFN-gamma production in
murine CD4+T cells. J Immunol. 174:1073–1080. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Imai M, Goepfert C, Kaczmarek E and Robson
SC: CD39 modulates IL-1 release from activated endothelial cells.
Biochem Biophys Res Commun. 270:272–278. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Warny M, Aboudola S, Robson SC, Sevigny J,
Communi D, Soltoff SP and Kelly CP: P2Y6nucleotide
receptor mediates monocyte interleukin-8 production in response to
UDP or lipopolysaccharide. J Biol Chem. 276:26051–26056. 2001.
|
|
10
|
la Sala A, Ferrari D, Corinti S, Cavani A,
Di Virgilio F and Girolomoni G: Extracellular ATP induces a
distorted maturation of dendritic cells and inhibits their capacity
to initiate Th1 responses. J Immunol. 166:1611–1617.
2001.PubMed/NCBI
|
|
11
|
Deaglio S, Dwyer KM, Gao W, et al:
Adenosine generation catalyzed by CD39 and CD73 expressed on
regulatory T cells mediates immune suppression. J Exp Med.
204:1257–1265. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang S, Apasov S, Koshiba M and Sitkovsky
M: Role of A2a extracellular adenosine receptor-mediated signaling
in adenosine-mediated inhibition of T-cell activation and
expansion. Blood. 90:1600–1610. 1997.PubMed/NCBI
|
|
13
|
Zhou L, Chong MM and Littman DR:
Plasticity of CD4+T cell lineage differentiation.
Immunity. 30:646–655. 2009.
|
|
14
|
Dong C: TH17 cells in development: an
updated view of their molecular identity and genetic programming.
Nat Rev Immunol. 8:337–348. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shi YH, Shi GC, Wan HY, et al: Coexistence
of Th1/Th2 and Th17/Treg imbalances in patients with allergic
asthma. Chin Med J (Engl). 124:1951–1956. 2011.PubMed/NCBI
|
|
16
|
Shi YH, Shi GC, Ma JY, AI XY, Zhu HX and
Wan HY: Expression of T-bet, GATA-3, RORγt and Foxp3 mRNA in the
peripheral blood of allergic asthma. Journal of Internal Medicine
Concepts and Practice. 6:113–116. 2011.(In Chinese).
|
|
17
|
Weaver CT, Harrington LE, Mangan PR,
Gavrieli M and Murphy KM: Th17: an effector CD4 T cell lineage with
regulatory T cell ties. Immunity. 24:677–688. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhu J, Yamane H, Cote-Sierra J, Guo L and
Paul WE: GATA-3 promotes Th2 responses through three different
mechanisms: induction of Th2 cytokine production, selective growth
of Th2 cells and inhibition of Th1 cell-specific factors. Cell Res.
16:3–10. 2006. View Article : Google Scholar
|
|
19
|
Chen Q, Yang W, Gupta S, et al:
IRF-4-binding protein inhibits interleukin-17 and interleukin-21
production by controlling the activity of IRF-4 transcription
factor. Immunity. 29:899–911. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ivanov II, McKenzie BS, Zhou L, et al: The
orphan nuclear receptor RORgammat directs the differentiation
program of proinflammatory IL-17+T helper cells. Cell.
126:1121–1133. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tesmer LA, Lundy SK, Sarkar S and Fox DA:
Th17 cells in human disease. Immunol Rev. 223:87–113. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Josefowicz SZ and Rudensky A: Control of
regulatory T cell lineage commitment and maintenance. Immunity.
30:616–625. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao J, Lloyd CM and Noble A: Th17
responses in chronic allergic airway inflammation abrogate
regulatory T-cell-mediated tolerance and contribute to airway
remodeling. Mucosal Immunol. 6:335–346. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shevach EM:
CD4+CD25+suppressor T cells: more questions
than answers. Nat Rev Immunol. 2:389–400. 2002.
|
|
25
|
Erpenbeck VJ, Hagenberg A, Krentel H, et
al: Regulation of GATA3, c-maf and T-bet mRNA expression in
bronchoalveolar lavage cells and bronchial biopsies after segmental
allergen challenge. Int Arch Allergy Immunol. 139:306–316. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Curotto de Lafaille MA, Kutchukhidze N,
Shen S, et al: Adaptive Foxp3+regulatory T
cell-dependent and -independent control of allergic inflammation.
Immunity. 29:114–126. 2008.
|
|
27
|
Borsellino G, Kleinewietfeld M, Di Mitri
D, et al: Expression of ectonucleotidase CD39 by
Foxp3+Treg cells: hydrolysis of extracellular ATP and
immune suppression. Blood. 110:1225–1232. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fletcher JM, Lonergan R, Costelloe L, et
al: CD39+Foxp3+regulatory T cells suppress
pathogenic Th17 cells and are impaired in multiple sclerosis. J
Immunol. 183:7602–7610. 2009.PubMed/NCBI
|
|
29
|
Ohta A, Kini R, Ohta A, Subramanian M,
Madasu M and Sitkovsky M: The development and immunosuppressive
functions of
CD4+CD25+FoxP3+regulatory T cells
are under influence of the adenosine-A2A adenosine receptor
pathway. Front Immunol. 3:1902012.
|
|
30
|
Michel ML, Pang DJ, Haque SF, Potocnik AJ,
Pennington DJ and Hayday AC: Interleukin 7 (IL-7) selectively
promotes mouse and human IL-17-producing γδ cells. Proc Natl Acad
Sci USA. 109:17549–17554. 2012.PubMed/NCBI
|
